Hemostatic changes in thyroid diseases

References

• Simone JV, Abildgaard CF, Schulman I. Blood coagulation in thyroid dysfunction. N Engl J Med 1965;273:1057–1061.
   PubMedGoogle Scholar
• Myrup B, Bregengird C, Faber J. Primary haemostasis and thyroid disease. J Intern Med 1995;238:59–63.
   Google Scholar
• Hofbauer LC, Heufelder AE. Coagulation disorders in thyroid diseases. Eur J Endocrinol 1997;136:1–7.
   PubMed Web of Science ®Google Scholar
• Rennie JA, Bewsher PD, Murchison LE, Ogston E. Coagulation and fibrinolysis in thyroid disease. Acta Haematol 1978;58:171–177.
   Google Scholar
• Franchini M. Hemostasis and thyroid diseases revisited. J Endocrinol Invest 2004;27:886–892.
   PubMed Web of Science ®Google Scholar
• Marongiu F, Cauli C, Mariotti S. Thyroid, hemostasis and thrombosis. J Endocrinol Invest 2004;27:1065–1071.
   Google Scholar
• Ford HC, Carter JM. Haemostasis in hypothyroidism. Postgrad Med J 1990;66:280–284.
   PubMedGoogle Scholar
• Erem C, Kavgaci H, Ersoz H, et al. Blood coagulation and fibrinolytic activity in hypothyroidism. Int J Chin Pract 2003;57:78–81.
   PubMed Web of Science ®Google Scholar
• Savage RA, Sipple C. Marrow myxedema. Arch Pathol Lab Med 1975;111:375–377.
   Google Scholar
• Berchtold P, Harris JP, Tani P, Piro L, McMillan R. Autoantibodies to platelet glycoproteins in patients with disease-related immune thrombocytopenia. Br J Haematol 1989;73:365–368.
   Google Scholar
• Hymes K, Blum M, Lackner H, Karpatkin S. Easy bruising, thrombocytopenia, and elevated platelet immunoglobulin G in Graves’ disease and Hashimoto’s thyroiditis. Ann Intern Med 1981;94:27–30.
   PubMed Web of Science ®Google Scholar
• Lamberg BA, Kivikangas V, Pelkonen R. Thrombocytopenia and decreased life-span of thrombocytes in hyperthyroidism. Ann Chin Res 1971;3:98–102.
   Google Scholar
• Marshall JS, Weisberger AS, Levy RP. Coexistent idiopathic thrombocytopenic purpura and hyperthyroidism. Ann Intern Med 1967;67:411–414.
   Google Scholar
• Kurata Y, Nishioeda Y, Tsubakio T, Kitani T. Thrombocy-topenia in Graves’ disease: Effect of T3 on platelet kinetics. Acta Haematol 1980;63:185–190.
   PubMed Web of Science ®Google Scholar
• Panzer S, Haubenstock A, Minar E. Platelets in hyperthyroid-ism: Studies on platelet counts, mean platelet volume, "indium labeled platelet kinetics and platelet associated immunoglobulins G and M. J Chin Endocrinol Metab 1990;70: 491–496.
   PubMed Web of Science ®Google Scholar
• Bizzaro N. Familial association of autoimmune thrombocyto-penia and hyperthyroidism. Am J Hematol 1992;39:294–298.
   PubMed Web of Science ®Google Scholar
• Adrouny A, Sandler R, Carmel R. Variable presentation of thrombocytopenia in Graves’ disease. Arch Intern Med 1982;142:1460–1464.
   Google Scholar
• Pinals RS, Tomar RH, Haas DC, Farah F. Graves’ disease, myasthenia gravis and purpura. Ann Intern Med 1977;87:250.
   PubMed Web of Science ®Google Scholar
• Yamaguchi K, Ookubo Y, Matsuda H, Suzaki K, Fujushima H, Uzwa H. Idiopathic thrombocytopenic purpura subsequent to Graves’ disease and insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1987;3:233–237.
   PubMed Web of Science ®Google Scholar
• Lio S, Albin M, Girelli G, et al. Abnormal thyroid function test results in patients with Fisher Evans syndrome. J Endocrinol Invest 1993;16:163–167 .
   PubMed Web of Science ®Google Scholar
• Crabtree GR, Lee JC, Cornwell GG. Autoimmune thrombo-cytopenic purpura and Hashimoto’s thyroiditis. Ann Intern Med 1975;83:371–372.
   Google Scholar
• Ho SL, Shah M, Williams AC. Idiopathic thrombocytopenic purpura and autoimmune thyroiditis in a patient with myasthenia gravis. Muscle Nerve 1992;15:966–967.
   Google Scholar
• Segal BM, Weintraub MI. Hashimoto’s thyroiditis, myasthenia gravis, idiopathic thrombocytopenic purpura. Ann Intern Med 1976;85:761–763.
   PubMed Web of Science ®Google Scholar
• Cordiano I, Betterle C, Spadaccino CA, Soini B, Girolami A, Fabris E Autoimmune thrombocytopenia (AITP) and thyroid autoimmune disease (TAD): Overlapping syndromes? Clin Exp Immunol 1998;113:373–378.
   PubMed Web of Science ®Google Scholar
• Hofbauer LC, Spitzweg C, Schmauss S, Heufelder AE. Graves disease associated with autoimmune thrombocytopenic purpura. Arch Intern Med 1997;157:1033–1036.
   PubMed Web of Science ®Google Scholar
• Zeigler ZR, Hasiba U, Lewis JH, Vagnucci AH, West VA, Bezek EA. Hemostatic defects in response to aspirin challenge in hypothyroidism. Am J Hematol 1986;17:209–215.
   Web of Science ®Google Scholar
• Hellem AJ, Segaard E, Solem JR. The adhesiveness of human blood platelets and thyroid function. Acta Med Scand 1975;197:15–17.
   PubMedGoogle Scholar
• Edson JR, Fecher DR, Doe RP. Low platelet adhesiveness and other abnormalities in hypothyroidism. Ann Intern Med 1975;82:342–346.
   Google Scholar
• Palareti G, Biagi G, Legnani C, et al. Association of reduced factor VIII with impaired platelet reactivity to adrenalin and collagen after total thyroidectomy. Thromb Haemost 1989;62:1053–1056.
   PubMed Web of Science ®Google Scholar
• Rogers JS, Shane SR, Jencks FS. Factor VIII activity and thyroid function. Ann Intern Med 1982;97:713–716.
   Google Scholar
• Rogers JS, Shane SR. Factor VIII activity in normal volunteers receiving oral thyroid hormone. J Lab Clin Med 1983; 102:444–449.
   PubMed Web of Science ®Google Scholar
• Gullu S, Say H, Kamel N. Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism. Eur J Endocrinol 2005;152:355–361.
   Google Scholar
• Dalton RG, Dewar MS, Savidge GF, et al. Hypothyroidism as a cause of acquired von Willebrand’s disease. Lancet 1987;1:1007–1009.
   PubMed Web of Science ®Google Scholar
• Smith SR, Anger MJ. Hypothyroidism and von Willebrand’s disease. Lancet 1987;1:1314.
   PubMedGoogle Scholar
• MacCallum PK, Rodgers M, Taberner DA. Hypothyroidism and von Willebrand’s disease. Lancet 1987;1:1314.
   PubMedGoogle Scholar
• Thornton JG, Parapia LA, Minford AMB. Hypothyroidism and von Willebrand’s disease. Lancet 1987;1:1314–1315.
   PubMedGoogle Scholar
• Nitu-Whalley IC, Lee CA. Acquired von Willebrand syndrome-report of 10 cases and review of the literature. Haemophilia 1999;5: 318–326.
   PubMed Web of Science ®Google Scholar
• Michiels JJ, Schroyens W, Berneman Z, van der Planken M. Acquired von Willebrand syndrome type 1 in hypothyroidism: Reversal after treatment with thyroxine. Clin Appl Thromb Hemost 2001;7: 113–115.
   PubMed Web of Science ®Google Scholar
• Franchini M, de Gironcoli M, Lippi G, et al. Efficacy of desmopressin as surgical prophylaxis in patients with acquired von Willebrand disease undergoing thyroid surgery. Haema-tologica 2002;8:142–144.
   Google Scholar
• Petrini P. Acquired von Willebrand disease. Haemophilia 1999;5 (Suppl. 2):68–69.
   PubMed Web of Science ®Google Scholar
• Attivissimo LA, Lichtman SM, Klein I. Acquired von Willebrand’s syndrome causing a hemorrhagic diathesis in a patient with hypothyroidism. Thyroid 1995;5:399–401.
   Google Scholar
• Blesing NE, Hambley H, McDonald GA. Acquired von Willebrand’s disease and hypothyroidism: Report of a case presenting with menorrhagia. Postgrad Med J 1990;66: 474–476.
   PubMed Web of Science ®Google Scholar
• Bruggers CS, McElligott K, Rallison ML. Acquired von Willebrand disease in twins with autoimmune hypothyroidism: Response to desmopressin and L-thyroxine therapy. J Pediatr 1994;125:911–913.
   PubMed Web of Science ®Google Scholar
• Levesque H, Borg JY, Cailleux N, et al. Acquired von Willebrand’s syndrome associated with decrease of plasmino-gen activator and its inhibitor during hypothyroidism. Eur J Med 1993;2:287–288.
   PubMedGoogle Scholar
• Rinder MR, Richard RE, Rinder HM. Acquired von Willebrand’s disease: A concise review. Am J Hematol 1997;54:139–145.
   PubMed Web of Science ®Google Scholar
• Aylesworth C, Smallridge RC, Rick ME, Alving BM. Acquired von Willebrand’s disease: A rare manifestation of postpartum thyroiditis. Am J Hematol 1995;50:217–219.
   PubMed Web of Science ®Google Scholar
• Tjan-Heijnen VCG, Harthoorn-Lasthuizen EJ, Kurstjens RMA, Koolen MI. A patient with postpartum primary hypothyroidism and acquired von Willebrand’s disease. Neth J Med 1994;44:91.
   PubMed Web of Science ®Google Scholar
• Soni S, Singh G, Yasir S, Hatipoglu B. An unusual presentation of hypothyroidism. Thyroid 2005;15:289–291.
   PubMed Web of Science ®Google Scholar
• Franchini M, Veneri D, Lippi G. Analysis of thyroid hormone status in 131 consecutive individuals with low von Willebrand factor levels. Thromb Haemost 2005;93: 392–393.
   PubMed Web of Science ®Google Scholar
• Meiklejohn DJ, Watson HG. Acquired haemophilia in association with organ-specific autoimmune disease. Haemo-philia 2001;7:523–525.
   PubMed Web of Science ®Google Scholar
• Graninger W, Pinch KR, Speiser W, Deutsch E, Waldhäusl WK. Effect of thyroid hormones on plasma protein concentration in man. J Clin Endocrinol Metab 1986;63: 407–411.
   PubMedGoogle Scholar
• Erfuth EM, Ericsson U-B, Egervall K, Lethagen SR. Effect of desmopressin and long-term thyroxine replacement on haemostasis in hypothyroidism. Clin Endocrinol (Oxf) 1995;42:373–378.
   PubMed Web of Science ®Google Scholar
• Van Oosterom AT, Kerkhoven P, Veltkamp H. Metabolism of the coagulation factors of the prothrombin complex in hypothyroidism in man. Thromb Haemost 1979;41:273–285.
   PubMedGoogle Scholar
• De Feo P. Hormonal regulation of human protein metabolism. Eur J Endocrinol 1996;135:7–18.
   PubMed Web of Science ®Google Scholar
• Egeberg BO. Influence of thyroid function on the blood clotting system. Scand J Clin Lab Invest 1963;15:1–7.
   Web of Science ®Google Scholar
• Nordoy A, Vikmo H, Berntsen H. Haemostatic and lipid abnormalities in hypothyroidism. Scand J Haematol 1976;16:154–160.
   PubMedGoogle Scholar
• Farid NR, Griffiths BL, Collins JR, Marshall WH, Ingram DW. Blood coagulation and fibrinolysis in thyroid disease. Thromb Haemost 1976;35:415–422.
   Google Scholar
• Marongiu F, Conti M, Murtas ML, Mameli G, Sorano GG, Martino E. Activation of blood coagulation in Graves’ disease. Horm Metab Res 1991;23:609–611.
   PubMed Web of Science ®Google Scholar
• Erem C, Ersöz H, Karti SS, et al. Blood coagulation and fibrinolysis in hyperthyroidism. J Endocrinol Invest 2002;25:345–350.
   PubMed Web of Science ®Google Scholar
• Marongiu F, Cauli C, Mameli G, Usai B, Mariotti S. Apatehtic Graves’ disease and acquired hemophilia due to factor VIIIc antibody. J Endocrinol Invest 2002;25:246–249.
   Google Scholar
• Sievert R, Goldstein ML, Surks MI. Graves’ disease and autoimmune factor VIII deficiency. Thyroid 1996;6:245–247.
   Google Scholar
• Rosen IB, Anderson I, Musclow CE. The factor of factor XI deficiency in thyroid neop la s ia . Surgery 1986;100: 1062–1067.
   Google Scholar
• Muller B, Tsakiris DA, Roth CB, Guglielmetti M, Staub JJ, Marbet GA. Haemostatic profile in hypothyroidism as potential risk for vascular or thrombotic disease. Eur J Clin Invest 2001;31:131–137.
   PubMed Web of Science ®Google Scholar
• Marongiu F, Biondi G, Conti M, et al. Is a hypercoagulable state present in hypothyroidism? Thromb Haemost 1992;67:729.
   PubMed Web of Science ®Google Scholar
• Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: The Rotterdam study. Ann Intern Med 2000;132:270–278.
   PubMed Web of Science ®Google Scholar
• Chadaverian R, Bruckert E, Ankri A, Beucler I, Giral P, Turpin G. Relationship between thyroid hormones and plasma D-dimer levels. Thromb Haemost 1998;79:99–103.
   PubMed Web of Science ®Google Scholar
• Fowkes FGR, Lowe GDO, Housley E, et al. Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet 1993;342:84–86.
   PubMed Web of Science ®Google Scholar
• Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med 1995;322:635–641.
   Google Scholar
• Chadarevian R, Bruckert E, Leenhardt L, Giral P, Ankri A, Turpin G. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. J Chin Endocrinol Metab 2001;86:732–737.
   PubMed Web of Science ®Google Scholar
• Chadarevian R, Jublanc C, Bruckert E, et al. Effect of levothyroxine replacement therapy on coagulation and fibrinolysis in severe hypothyroidism. J Endocrinol Invest 2005;28:398–404.
   PubMed Web of Science ®Google Scholar
• Guldiken S, Demir M, Turgut B, Altun BU, Arikan E, Kara M. Global fibrinolytic capacity in patients with subclinical hypothyroidism. Endocr J 2005;52:363–367.
   PubMed Web of Science ®Google Scholar
• Ozcan MA, Comlekgi A, Demrkan F, et al. Plasma levels of free tissue factor pathway inhibitor in patients with various thyroid disorders. Thromb Res 2003;110:243–247.
   PubMed Web of Science ®Google Scholar
• Catargi B, Parrot-Roulaud F, Cochet C, Ducassou D, Roger P, Tabarin A. Homocysteine, hypothyroidism, and effect of thyroid hormone replacement. Thyroid 1999;9:1163–1166.
   PubMed Web of Science ®Google Scholar
• Marongiu F, Conti M, Murtas ML, et al. Anticardiolipin antibodies in Grave’s disease: Relationship with thrombin activity in vivo. Thromb Res 1991;64:745–749.
   PubMed Web of Science ®Google Scholar
• Paggi A, Caccavo D, Ferri GM, et al. Anticardiolipin antibodies in autoimmune thyroid disease. Chin Endocrinol 1994;40:329–333.
   PubMed Web of Science ®Google Scholar
• Hofbauer LC, Spitzweg C, Heufelder AE. Graves’ disease associated with the primary antiphospholipid syndrome. J Rheumatol 1996;23:1435–1437.
   Google Scholar
• Takahashi A, Tamura A, Ishikawa O. Antiphospholipid antibody syndrome complicated by Graves’ disease. J Dermatol 2002;29:776–780.
   Google Scholar
• Osundeko O, Hasinski S, Rose U. Anticardiolipin antibodies in Hashimoto’s disease. Endocr Pract 2001;7:181–183.
   PubMedGoogle Scholar
• Nabriski D, Ellis M, Ness-Abramof R, Shapiro M, Shenkman L. Autoimmune thyroid disease and antiphospholipid anti-bodies. Am J Hematol 2000;64:73–75.
   Google Scholar
• Dagenais P, Urowitz MB, Gladman DD, Norman CS. A family study of the antiphospholipid syndrome associated with other autoimmune diseases. J Rheumatol 1992;19: 1393–1396.
   PubMed Web of Science ®Google Scholar
• Loeliger EA, Esch B. The biological disappearance rate of prothrombin, factors VII, and X from plasma in hypothyroid-ism, hyperthyroidism, and during fever. Thromb Diathes Haemorrh 1963;10:267–277.
   Google Scholar
• Kellet HA, Sawers JSA, Boulton FE, Cholerton S, Park BK, Toft AD. Problems of anticoagulation with warfarin in hyperthyroidism. Q Med J 1986;58:43–51.
   PubMedGoogle Scholar
• Burggraaf J, Lalezari S, Emeis JJ, et al. Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol. Thyroid 2001;2:153–160.
   Web of Science ®Google Scholar
• Liu L, Wang X, Lin Z, Wu H. Elevated plasma levels of vWF:ag in hyperthyroidism are mediated through beta-adrenergic receptors. Endocrine Res 1993;19:123–133.
   PubMed Web of Science ®Google Scholar
• Morikawa Y, Morikawa A, Makin° I. Relationship of thyroid states and serum thrombomodulin (TM) levels in patients with Grave’s disease: TM a possible new marker of the peripheral activity of thyroid hormones. J Chin Endocrinol Metab 1993;76:609–614.
   PubMed Web of Science ®Google Scholar
• Chen YL, Tan J, Wang X, Liang H, Sun X. Impaired release of tissue plasminogen activator from the endothelium in Graves’ disease-indicator of endothelial dysfunction and reduced fibrinolytic capacity. Eur J Chin Invest 1998;28:1050–1054.
   Google Scholar
• Morishita E, Hashimoto T, Asakura H, et al. Increased plasma levels of free tissue factor pathway inhibitor in patients with Graves’ disease. Thromb Haemost 1998;79:919–923.
   PubMed Web of Science ®Google Scholar
• Chadaverian R, Bruckert E, Giral P, Turpin G. Relationship between thyroid hormones and fibrinogen levels. Blood Coagul Fibrinolysis 1999;10:481–486.
   PubMed Web of Science ®Google Scholar
• Grant PJ, Medcalf RL. Hormonal regulation of haemostasis and the molecular biology of the fibrinolytic system. Chin Sci 1990;78:3–11.
   Google Scholar
• Marongiu F, Conti M, Mameli G, et al. Fibrinogen and fibrinolytic activity in hyperthyroidism before and after antithyroid treatment. J Endocrinol Invest 1988;11:723–725.
   PubMed Web of Science ®Google Scholar
• Tiede DJ, Tefferi A, Kochhar R, Thompson GB, Hay ID. Paraneoplastic cholestasis and hypercoagulability associated with medullary thyroid carcinoma. Cancer 1994;73:702–705.
   Google Scholar
• Raveh E, Cohen M, Shpitzer T, Feinmesser R. Carcinoma of the thyroid: A cause of hypercoagulability? Ear Nose Throat J 1995;74:110–112.
   PubMedGoogle Scholar
• Sagripanti A, Carpi A, Baicchi U. The measurement of plasma D-dimer in the follow-up after thyroidectomy for cancer: Preliminary data. Thyroidol 1991;3:31–35.
   Google Scholar